0001047469-19-001721 Sample Contracts

AMENDMENT NO. 1 TO LETTER AGREEMENT
Letter Agreement • March 28th, 2019 • Aridis Pharmaceuticals, Inc. • Pharmaceutical preparations

This Amendment No. 1 ("Amendment No. 1") to the Development Program Letter Agreement is entered into and effective as of November 26, 2018 ("Amendment No. 1 Effective Date") by and between Aridis Pharmaceuticals, Inc. ("Aridis") and Cystic Fibrosis Foundation Therapeutics, Inc. ("CFFT").

AutoNDA by SimpleDocs
Time is Money Join Law Insider Premium to draft better contracts faster.